作者
Rayid Abdulqawi, Rachel Dockry, Kimberley Holt, Gary Layton, Bruce G McCarthy, Anthony P Ford, Jaclyn A Smith
发表日期
2015/3/28
期刊
The Lancet
卷号
385
期号
9974
页码范围
1198-1205
出版商
Elsevier
简介
Background
Preclinical studies suggest that P2X3 receptors are expressed by airway vagal afferent nerves and contribute to the hypersensitisation of sensory neurons. P2X3 receptors could mediate sensitisation of the cough reflex, leading to chronic cough. We aimed to investigate the efficacy of a first-in-class oral P2X3 antagonist, AF-219, to reduce cough frequency in patients with refractory chronic cough.
Methods
We did a double-blind, placebo-controlled, two-period, crossover study at one UK centre. With a computer-generated sequence, we randomly assigned patients with refractory chronic cough to AF-219, 600 mg twice a day, or to placebo (1:1), and then, after a 2 week washout, assigned patients to receive the other treatment. Patients, health-care providers, and investigators were masked to sequence assignment. We assessed daytime cough frequency (primary endpoint) at baseline and after 2 weeks of …
引用总数
201520162017201820192020202120222023202421485152647666505016